New report shows how long term investment in novel products like cell and gene therapies is beginning to bear fruit. The concern now is the price of these products and ensuring patients get access
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.